Cristina Salabao, MSN, FNP-C, AOCNP provides key updates on the use of available regimens in renal cell carcinoma (RCC) across the adjuvant, first-line, and second-line settings.
Oncology NPs, PAs, and RNs
This program is supported by educational grants from Merck Sharp & Dohme Corp; Regeneron Pharmaceuticals, Inc. and Sanofi; and Taiho Oncology, Inc.
Cristina Salabao, MSN, FNP-C, AOCNP, has no relevant financial relationships to disclose.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 105722O-CT3